Saltigo Press Conference 2008
Press Kit
Saltigo: Growth through investment and innovation
 |
Saltigo GmbH, a wholly owned subsidiary of the LANXESS specialty chemicals group, has now officially inaugurated a state-of-the-art multi-purpose unit for the production of active pharmaceutical ingredients and intermediates.
Saltigo-1e.jpg | |||
Saltigo-2e.jpg | |||
Saltigo-3e.jpg | |||
Saltigo-4e.jpg | |||
Saltigo-5e.jpg |
Saltigo – Experienced partner of innovative industries
 |
Address by Wolfgang Schmitz, Managing Director Saltigo GmbH
Pharma outsourcing: Challenges + opportunities
 |
Address by Ann Gidner, Head of Marketing & Sales Business Line Pharma Saltigo GmbH
February 14, 2008 | Speeches, Saltigo
The new CGMP plant: Modern, flexible, efficient
 |
Address by Dr. Karl-Heinz Duchêne, Head of Manufacturing Strategy Business Line Pharma Saltigo GmbH
Noted pages
